<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://www.clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/207b72ab-f0ee-4799-93c8-98c836929f9a/D9A4483C-140D-4122-B7D3-6D676ED15CC0/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.medpagetoday.com/MeetingCoverage/CHEST/16810?impressionId=1257428595971&userid=227603&utm_source=mSpoke&utm_medium=widget&utm_campaign=MyNews&utm_content=GroupD" href="http://www.medpagetoday.com/MeetingCoverage/CHEST/16810?impressionId=1257428595971&userid=227603&utm_source=mSpoke&utm_medium=widget&utm_campaign=MyNews&utm_content=GroupD" style="font-size: 11px;">www.medpagetoday.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.medpagetoday.com/MeetingCoverage/CHEST/16810?impressionId=1257428595971&userid=227603&utm_source=mSpoke&utm_medium=widget&utm_campaign=MyNews&utm_content=GroupD"><DIV>SAN DIEGO -- Much as it aided the general population of smokers, varenicline (Chantix) helped patients with chronic obstructive pulmonary disease (COPD) quit too, a randomized trial showed.</DIV></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.medpagetoday.com/MeetingCoverage/CHEST/16810?impressionId=1257428595971&userid=227603&utm_source=mSpoke&utm_medium=widget&utm_campaign=MyNews&utm_content=GroupD"><DIV>From weeks nine to 12 of treatment, 42.3% of those taking varenicline remained abstinent, compared with 8.8% of those taking placebo (<EM>P</EM>&lt;0.001), Donald Tashkin, MD, of the University of California Los Angeles, reported at the American College of Chest Physicians meeting here.</DIV></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.medpagetoday.com/MeetingCoverage/CHEST/16810?impressionId=1257428595971&userid=227603&utm_source=mSpoke&utm_medium=widget&utm_campaign=MyNews&utm_content=GroupD"><P>Varenicline and bupropion are the two first-line pharmacologic aids for smoking cessation recommended by the Department of Health and Human Services' Public Health Service in guidelines updated in 2008.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.medpagetoday.com/MeetingCoverage/CHEST/16810?impressionId=1257428595971&userid=227603&utm_source=mSpoke&utm_medium=widget&utm_campaign=MyNews&utm_content=GroupD"><P>There was one report of aggression in the varenicline group. Reports of anxiety, depression, depressed mood, and depressive symptoms were infrequent and similar in number between the two groups.</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/D9A4483C-140D-4122-B7D3-6D676ED15CC0/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!